GPT and cancer: Serious TEAEs occurred in 2 of 11 (18%) patients: 1 patient had increased ALT, AST, ALP, and blood bilirubin, and 1 patient experienced anemia as well as malignant neoplasm progression (grade 5), which resulted in death and was considered unrelated to the study drug.